Ange-Line Bruel
University of Burgundy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ange-Line Bruel.
Nature Genetics | 2014
Christel Thauvin-Robinet; Jaclyn S Lee; Estelle Lopez; Vicente Herranz-Pérez; Toshinobu Shida; Brunella Franco; Laurence Jego; Fan Ye; Laurent Pasquier; Philippe Loget; Nadège Gigot; Bernard Aral; Carla A. M. Lopes; Judith St-Onge; Ange-Line Bruel; Julien Thevenon; Susana González-Granero; Caroline Alby; Arnold Munnich; Michel Vekemans; Frédéric Huet; Andrew M. Fry; Sophie Saunier; Jean-Baptiste Rivière; Tania Attié-Bitach; Jose Manuel Garcia-Verdugo; Laurence Faivre; André Mégarbané; Maxence V. Nachury
Centrioles are microtubule-based, barrel-shaped structures that initiate the assembly of centrosomes and cilia. How centriole length is precisely set remains elusive. The microcephaly protein CPAP (also known as MCPH6) promotes procentriole growth, whereas the oral-facial-digital (OFD) syndrome protein OFD1 represses centriole elongation. Here we uncover a new subtype of OFD with severe microcephaly and cerebral malformations and identify distinct mutations in two affected families in the evolutionarily conserved C2CD3 gene. Concordant with the clinical overlap, C2CD3 colocalizes with OFD1 at the distal end of centrioles, and C2CD3 physically associates with OFD1. However, whereas OFD1 deletion leads to centriole hyperelongation, loss of C2CD3 results in short centrioles without subdistal and distal appendages. Because C2CD3 overexpression triggers centriole hyperelongation and OFD1 antagonizes this activity, we propose that C2CD3 directly promotes centriole elongation and that OFD1 acts as a negative regulator of C2CD3. Our results identify regulation of centriole length as an emerging pathogenic mechanism in ciliopathies.
Nature Cell Biology | 2016
Nils J. Lambacher; Ange-Line Bruel; Teunis J. P. van Dam; Katarzyna Szymanska; Gisela G. Slaats; Stefanie Kuhns; Gavin J. McManus; Julie Kennedy; Karl Gaff; Ka Man Wu; Robin van der Lee; Lydie Burglen; Diane Doummar; Jean-Baptiste Rivière; Laurence Faivre; Tania Attié-Bitach; Sophie Saunier; Alistair Curd; Michelle Peckham; Rachel H. Giles; Colin A. Johnson; Martijn A. Huynen; Christel Thauvin-Robinet; Oliver E. Blacque
The transition zone (TZ) ciliary subcompartment is thought to control cilium composition and signalling by facilitating a protein diffusion barrier at the ciliary base. TZ defects cause ciliopathies such as Meckel–Gruber syndrome (MKS), nephronophthisis (NPHP) and Joubert syndrome (JBTS). However, the molecular composition and mechanisms underpinning TZ organization and barrier regulation are poorly understood. To uncover candidate TZ genes, we employed bioinformatics (coexpression and co-evolution) and identified TMEM107 as a TZ protein mutated in oral–facial–digital syndrome and JBTS patients. Mechanistic studies in Caenorhabditis elegans showed that TMEM-107 controls ciliary composition and functions redundantly with NPHP-4 to regulate cilium integrity, TZ docking and assembly of membrane to microtubule Y-link connectors. Furthermore, nematode TMEM-107 occupies an intermediate layer of the TZ-localized MKS module by organizing recruitment of the ciliopathy proteins MKS-1, TMEM-231 (JBTS20) and JBTS-14 (TMEM237). Finally, MKS module membrane proteins are immobile and super-resolution microscopy in worms and mammalian cells reveals periodic localizations within the TZ. This work expands the MKS module of ciliopathy-causing TZ proteins associated with diffusion barrier formation and provides insight into TZ subdomain architecture.
Nature Genetics | 2016
Michinori Toriyama; Chanjae Lee; S. Paige Taylor; Ivan Duran; Daniel H. Cohn; Ange-Line Bruel; Jacqueline M. Tabler; Kevin Drew; Marcus R. Kelly; Sukyoung Kim; Tae Joo Park; Daniela A. Braun; Geneviève Pierquin; Armand Biver; Kerstin Wagner; Anne Malfroot; Inusha Panigrahi; Brunella Franco; Hadeel Adel Al-Lami; Yvonne Yeung; Yeon Ja Choi; Yannis Duffourd; Laurence Faivre; Jean-Baptiste Rivière; Jiang Chen; Karen J. Liu; Edward M. Marcotte; Friedhelm Hildebrandt; Christel Thauvin-Robinet; Deborah Krakow
Cilia use microtubule-based intraflagellar transport (IFT) to organize intercellular signaling. Ciliopathies are a spectrum of human diseases resulting from defects in cilia structure or function. The mechanisms regulating the assembly of ciliary multiprotein complexes and the transport of these complexes to the base of cilia remain largely unknown. Combining proteomics, in vivo imaging and genetic analysis of proteins linked to planar cell polarity (Inturned, Fuzzy and Wdpcp), we identified and characterized a new genetic module, which we term CPLANE (ciliogenesis and planar polarity effector), and an extensive associated protein network. CPLANE proteins physically and functionally interact with the poorly understood ciliopathy-associated protein Jbts17 at basal bodies, where they act to recruit a specific subset of IFT-A proteins. In the absence of CPLANE, defective IFT-A particles enter the axoneme and IFT-B trafficking is severely perturbed. Accordingly, mutation of CPLANE genes elicits specific ciliopathy phenotypes in mouse models and is associated with ciliopathies in human patients.
Journal of Medical Genetics | 2017
Ange-Line Bruel; Brunella Franco; Yannis Duffourd; Julien Thevenon; Laurence Jego; Estelle Lopez; Jean-François Deleuze; Diane Doummar; Rachel H. Giles; Colin A. Johnson; Martijn A. Huynen; Véronique Chevrier; Lydie Burglen; Manuela Morleo; Isabelle Desguerres; Geneviève Pierquin; Bérénice Doray; Brigitte Gilbert-Dussardier; Bruno Reversade; Elisabeth Steichen-Gersdorf; Clarisse Baumann; Inusha Panigrahi; Anne Fargeot-Espaliat; Anne Dieux; Albert David; Alice Goldenberg; Ernie M.H.F. Bongers; Dominique Gaillard; Jesus Argente; Bernard Aral
Oral–facial–digital syndromes (OFDS) gather rare genetic disorders characterised by facial, oral and digital abnormalities associated with a wide range of additional features (polycystic kidney disease, cerebral malformations and several others) to delineate a growing list of OFDS subtypes. The most frequent, OFD type I, is caused by a heterozygous mutation in the OFD1 gene encoding a centrosomal protein. The wide clinical heterogeneity of OFDS suggests the involvement of other ciliary genes. For 15 years, we have aimed to identify the molecular bases of OFDS. This effort has been greatly helped by the recent development of whole-exome sequencing (WES). Here, we present all our published and unpublished results for WES in 24 cases with OFDS. We identified causal variants in five new genes (C2CD3, TMEM107, INTU, KIAA0753 and IFT57) and related the clinical spectrum of four genes in other ciliopathies (C5orf42, TMEM138, TMEM231 and WDPCP) to OFDS. Mutations were also detected in two genes previously implicated in OFDS. Functional studies revealed the involvement of centriole elongation, transition zone and intraflagellar transport defects in OFDS, thus characterising three ciliary protein modules: the complex KIAA0753-FOPNL-OFD1, a regulator of centriole elongation; the Meckel-Gruber syndrome module, a major component of the transition zone; and the CPLANE complex necessary for IFT-A assembly. OFDS now appear to be a distinct subgroup of ciliopathies with wide heterogeneity, which makes the initial classification obsolete. A clinical classification restricted to the three frequent/well-delineated subtypes could be proposed, and for patients who do not fit one of these three main subtypes, a further classification could be based on the genotype.
European Journal of Human Genetics | 2017
Salima El Chehadeh; Wilhelmina S. Kerstjens-Frederikse; Julien Thevenon; Paul Kuentz; Ange-Line Bruel; Christel Thauvin-Robinet; Candace Bensignor; Hélène Dollfus; Vincent Laugel; Jean-Baptiste Rivière; Yannis Duffourd; Caroline Bonnet; Matthieu P. Robert; Rodica Isaiko; Morgane Straub; C. Creuzot-Garcher; Patrick Calvas; Nicolas Chassaing; Bart Loeys; Edwin Reyniers; Geert Vandeweyer; Frank Kooy; Miroslava Hancarova; Marketa Havlovicova; Darina Prchalova; Zdenek Sedlacek; Christian Gilissen; Rolph Pfundt; Jolien S. Klein Wassink-Ruiter; Laurence Faivre
Verheij syndrome, also called 8q24.3 microdeletion syndrome, is a rare condition characterized by ante- and postnatal growth retardation, microcephaly, vertebral anomalies, joint laxity/dislocation, developmental delay (DD), cardiac and renal defects and dysmorphic features. Recently, PUF60 (Poly-U Binding Splicing Factor 60 kDa), which encodes a component of the spliceosome, has been discussed as the best candidate gene for the Verheij syndrome phenotype, regarding the cardiac and short stature phenotype. To date, only one patient has been reported with a de novo variant in PUF60 that probably affects function (c.505C>T leading to p.(His169Tyr)) associated with DD, microcephaly, craniofacial and cardiac defects. Additional patients were required to confirm the pathogenesis of this association and further delineate the clinical spectrum. Here we report five patients with de novo heterozygous variants in PUF60 identified using whole exome sequencing. Variants included a splice-site variant (c.24+1G>C), a frameshift variant (p.(Ile136Thrfs*31)), two nonsense variants (p.(Arg448*) and p.(Lys301*)) and a missense change (p.(Val483Ala)). All six patients with a PUF60 variant (the five patients of the present study and the unique reported patient) have the same core facial gestalt as 8q24.3 microdeletions patients, associated with DD. Other findings include feeding difficulties (3/6), cardiac defects (5/6), short stature (5/6), joint laxity and/or dislocation (5/6), vertebral anomalies (3/6), bilateral microphthalmia and irido–retinal coloboma (1/6), bilateral optic nerve hypoplasia (2/6), renal anomalies (2/6) and branchial arch defects (2/6). These results confirm that PUF60 is a major driver for the developmental, craniofacial, skeletal and cardiac phenotypes associated with the 8q24.3 microdeletion.
Human Molecular Genetics | 2016
Véronique Chevrier; Ange-Line Bruel; Teunis J. P. van Dam; Brunella Franco; Melissa Lo Scalzo; Frédérique Lembo; Stéphane Audebert; Emilie Baudelet; Daniel Isnardon; Angélique Bole; Paul Borg; Paul Kuentz; Julien Thevenon; Lydie Burglen; Laurence Faivre; Jean-Baptiste Rivière; Martijn A. Huynen; Daniel Birnbaum; Olivier Rosnet; Christel Thauvin-Robinet
Oral-facial-digital (OFD) syndromes are rare heterogeneous disorders characterized by the association of abnormalities of the face, the oral cavity and the extremities, some due to mutations in proteins of the transition zone of the primary cilia or the closely associated distal end of centrioles. These two structures are essential for the formation of functional cilia, and for signaling events during development. We report here causal compound heterozygous mutations of KIAA0753/OFIP in a patient with an OFD VI syndrome. We show that the KIAA0753/OFIP protein, whose sequence is conserved in ciliated species, associates with centrosome/centriole and pericentriolar satellites in human cells and forms a complex with FOR20 and OFD1. The decreased expression of any component of this ternary complex in RPE1 cells causes a defective recruitment onto centrosomes and satellites. The OFD KIAA0753/OFIP mutant loses its capacity to interact with FOR20 and OFD1, which may be the molecular basis of the defect. We also show that KIAA0753/OFIP has microtubule-stabilizing activity. OFD1 and FOR20 are known to regulate the integrity of the centriole distal end, confirming that this structural element is a target of importance for pathogenic mutations in ciliopathies.
Genetics in Medicine | 2018
Sophie Nambot; Julien Thevenon; Paul Kuentz; Yannis Duffourd; Emilie Tisserant; Ange-Line Bruel; Anne-Laure Mosca-Boidron; Alice Masurel-Paulet; Daphné Lehalle; Nolwenn Jean-Marçais; Mathilde Lefebvre; Pierre Vabres; Salima El Chehadeh-Djebbar; Christophe Philippe; Frederic Tran Mau-Them; Judith St-Onge; Thibaud Jouan; Martin Chevarin; Charlotte Poe; Virginie Carmignac; Antonio Vitobello; Patrick Callier; Jean-Baptiste Rivière; Laurence Faivre; Christel Thauvin-Robinet
PurposeCongenital anomalies and intellectual disability (CA/ID) are a major diagnostic challenge in medical genetics—50% of patients still have no molecular diagnosis after a long and stressful diagnostic “odyssey.” Solo clinical whole-exome sequencing (WES) was applied in our genetics center to improve diagnosis in patients with CA/ID.MethodsThis retrospective study examined 416 consecutive tests performed over 3 years to demonstrate the effectiveness of periodically reanalyzing WES data. The raw data from each nonpositive test was reanalyzed at 12 months with the most recent pipeline and in the light of new data in the literature. The results of the reanalysis for patients enrolled in the third year are not yet available.ResultsOf the 416 patients included, data for 156 without a diagnosis were reanalyzed. We obtained 24 (15.4%) additional diagnoses: 12 through the usual diagnostic process (7 new publications, 4 initially misclassified, and 1 copy-number variant), and 12 through translational research by international data sharing. The final yield of positive results was 27.9% through a strict diagnostic approach, and 2.9% through an additional research strategy.ConclusionThis article highlights the effectiveness of periodically combining diagnostic reinterpretation of clinical WES data with translational research involving data sharing for candidate genes.
Prenatal Diagnosis | 2015
Mathilde Lefebvre; Fabienne Dufernez; Ange-Line Bruel; Marie Gonzales; Bernard Aral; Judith Saint-Onge; Nadège Gigot; Julie Désir; Caroline Daelemans; Frédérique Jossic; Sébastien Schmitt; Raphaële Mangione; Fanny Pelluard; Catherine Vincent-Delorme; Jean-Marc Labaune; Nicole Bigi; Dominique D'Olne; Anne-Lise Delezoide; Annick Toutain; Sophie Blesson; Valérie Cormier-Daire; Julien Thevenon; Salima El Chehadeh; Alice Masurel-Paulet; Nicole Joyé; Claude Vibert-Guigue; Luc Rigonnot; Thierry Rousseau; Pierre Vabres; Philippe Hervé
Conradi–Hünermann–Happle [X‐linked dominant chondrodysplasia punctata 2 (CDPX2)] syndrome is a rare X‐linked dominant skeletal dysplasia usually lethal in men while affected women show wide clinical heterogeneity. Different EBP mutations have been reported. Severe female cases have rarely been reported, with only six antenatal presentations.
American Journal of Medical Genetics Part A | 2017
Alexandra Gauthier-Vasserot; Christel Thauvin-Robinet; Ange-Line Bruel; Yannis Duffourd; Judith St-Onge; Thibaud Jouan; Jean-Baptiste Rivière; Delphine Héron; Jean Donadieu; Christine Bellanné-Chantelot; Claire Briandet; Frédéric Huet; Paul Kuentz; Daphné Lehalle; Laurence Duplomb-Jego; Elodie Gautier; Isabelle Maystadt; Lucile Pinson; Daniel Amram; Salima El Chehadeh; Judith Melki; Sophia Julia; Laurence Faivre; Julien Thevenon
Neutropenia can be qualified as congenital when of neonatal onset or when associated with extra‐hematopoietic manifestations. Overall, 30% of patients with congenital neutropenia (CN) remain without a molecular diagnosis after a multidisciplinary consultation and tedious diagnostic strategy. In the rare situations when neutropenia is identified and associated with intellectual disability (ID), there are few diagnostic hypotheses to test. This retrospective multicenter study reports on a clinically heterogeneous cohort of 10 unrelated patients with CN associated with ID and no molecular diagnosis prior to whole‐exome sequencing (WES). WES provided a diagnostic yield of 40% (4/10). The results suggested that in many cases neutropenia and syndromic manifestations could not be assigned to the same molecular alteration. Three sub‐groups of patients were highlighted: (i) severe, symptomatic chronic neutropenia, detected early in life, and related to a known mutation in the CN spectrum (ELANE); (ii) mild to moderate benign intermittent neutropenia, detected later, and associated with mutations in genes implicated in neurodevelopmental disorders (CHD2, HUWE1); and (iii) moderate to severe intermittent neutropenia as a probably undiagnosed feature of a newly reported syndrome (KAT6A). Unlike KAT6A, which seems to be associated with a syndromic form of CN, the other reported mutations may not explain the entire clinical picture. Although targeted gene sequencing can be discussed for the primary diagnosis of severe CN, we suggest that performing WES for the diagnosis of disorders associating CN with ID will not only provide the etiological diagnosis but will also pave the way towards personalized care and follow‐up.
Clinical Genetics | 2017
Ange-Line Bruel; Alice Masurel-Paulet; Jean-Baptiste Rivière; Yannis Duffourd; Daphné Lehalle; Candace Bensignor; Frédéric Huet; Joséphine Borgnon; Florence Roucher; Paul Kuentz; Jean-François Deleuze; Christel Thauvin-Robinet; Laurence Faivre; Julien Thevenon
We report on a boy with a rare malformative association of scrotum agenesis, ophthalmological anomalies, cerebellar malformation, facial dysmorphism and global development delay. The reported patient was carrying a homozygous frameshift in MAB21L1 detected by whole‐exome sequencing, considered as the most likely disease‐causing variant. Mab21l1 knockout mice present a strikingly similar malformative association of ophthalmological malformations of the anterior chamber and preputial glands hypoplasia. We hypothesize that MAB21L1 haploinsufficiency cause a previously undescribed syndrome with scrotal agenesis, ophthalmological anomalies, facial dysmorphism and gross psychomotor delay as remarkable hallmarks. Four cases from the literature were reported with features suggestive of a similar and recognizable clinical entity. We hypothesize that MAB21L1 should be the culprit gene in these patients.